COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Last week, the Food and Drug Administration (FDA) issued an emergency use authorization (EAU) for the first serology test
EvergreenHealth is located in Kirkland, Wash., just outside of Seattle and was the first hospital in the country to treat a wave of patients diagnosed with community-spread COVID-19.
Coverage for telehealth services, which was approved on an emergency basis during the COVID-19 pandemic, will become standard for patients receiving home-based health
The American Hospital Association (AHA) delivered comments to the Centers for Medicare & Medicaid Services
The American Hospital Association’s (AHA) Center for Health Innovation partnered with the Centers for Disease Control and Prevention.
In its Morbidity and Mortality Weekly Report (MMWR), the Centers for Disease Control and Prevention (CDC) reported early increases in the rate of positive test results for Americans younger than age 25 living in 767 COVID-19 hotspot counties in June and July.
An analysis of Centers for Disease Control and Prevention (CDC) data collected from mid-February to mid-July found nurses predominated among health care professionals (HCPs) who contracted COVID-19.
Last week, the Food and Drug Administration (FDA) issued its first emergency use authorization for a point-of-care COVID-19 antibody test.
Technical guidance to support effective use of antigen tests in various testing situations was updated this week by the Centers for Disease Control and Prevention (CDC). The guidance summarizes the differences between diagnostic, screening, and surveillance testing and provides links to regulatory…